Buescher E S, Malinowska I
Department of Pediatrics, Eastern Virginia Medical School, Children's Hospital of The King's Daughters, Norfolk, USA.
Pediatr Res. 1996 Dec;40(6):839-44. doi: 10.1203/00006450-199612000-00011.
To determine whether human milk contained soluble receptors and cytokine antagonists that might contribute to its anti-inflammatory properties, ELISA and enzyme-amplified sensitivity immunoassay methods were used to quantitate soluble intercellular and vascular cell adhesion molecules, soluble E-selectin, soluble IL-6 receptor, IL-1 receptor antagonist, and soluble tumor necrosis factor-alpha (TNF-alpha) receptors I and II in human milk and colostrum. Soluble adhesion receptors (soluble intercellular and vascular cell adhesion molecules and soluble E-selectin) were present in colostrum at levels approximately equal to serum, whereas milk levels were significantly lower. Both colostrum and milk contained soluble IL-6 receptor, but the levels present were significantly lower than that reported for serum. The colostrum contents of IL-1 receptor antagonist (672 +/- 202 pg/mL), TNF-alpha receptor I (> 3703 +/- 305 pg/mL), and TNF-alpha receptor II (> 4507 +/- 770 pg/mL) were significantly elevated over serum/plasma levels. Milk levels of IL-1 receptor antagonist and TNF-alpha receptor I were also greater than serum/ plasma levels, but lower than colostrum levels. Examination of sequential milk specimens collected from seven women over a period of 2-6 mo showed that IL-1 receptor antagonist and TNF-alpha receptors I and II persisted throughout lactation. Column chromatographic fractionation of colostrum and milk demonstrated that soluble TNF-alpha receptors I and II had molecular sizes up to 60 kD, suggesting that they might be associated with other molecules. Antigen assays for TNF-alpha in colostrum and milk, as well as chromatographic fractionation experiments, showed that, although present, most TNF-alpha was not "free" in colostrum or milk, consistent with the observed content of soluble TNF-alpha receptors I and II. These studies demonstrate that human milk and colostrum contain soluble receptors and cytokine antagonists, materials which could contribute to their anti-inflammatory properties.
为了确定人乳中是否含有可能有助于其抗炎特性的可溶性受体和细胞因子拮抗剂,采用酶联免疫吸附测定(ELISA)和酶放大灵敏度免疫测定方法,对人乳和初乳中的可溶性细胞间黏附分子、血管细胞黏附分子、可溶性E选择素、可溶性白细胞介素-6(IL-6)受体、IL-1受体拮抗剂以及可溶性肿瘤坏死因子-α(TNF-α)受体I和II进行定量分析。初乳中可溶性黏附受体(可溶性细胞间黏附分子、血管细胞黏附分子和可溶性E选择素)的水平与血清大致相当,而乳中的水平则显著较低。初乳和乳中均含有可溶性IL-6受体,但其水平显著低于血清中的报道水平。初乳中IL-1受体拮抗剂(672±202 pg/mL)、TNF-α受体I(>3703±305 pg/mL)和TNF-α受体II(>4507±770 pg/mL)的含量显著高于血清/血浆水平。乳中IL-1受体拮抗剂和TNF-α受体I的水平也高于血清/血浆水平,但低于初乳水平。对7名女性在2至6个月期间收集的连续乳汁样本进行检测发现,IL-1受体拮抗剂以及TNF-α受体I和II在整个哺乳期均持续存在。对初乳和乳进行柱色谱分离表明,可溶性TNF-α受体I和II的分子大小可达60 kD,这表明它们可能与其他分子相关联。对初乳和乳中TNF-α的抗原检测以及色谱分离实验表明,尽管初乳和乳中存在TNF-α,但大多数TNF-α并非“游离”状态,这与观察到的可溶性TNF-α受体I和II的含量相符。这些研究表明,人乳和初乳中含有可溶性受体和细胞因子拮抗剂,这些物质可能有助于它们的抗炎特性。